Clinical Trials Browser

Withdrawn × Pancreatic Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00728000 2019-11-25

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms